Examining HPV Vaccination Practices and Differences Among Providers in Virginia
Virginia has some of the lowest HPV vaccination rates, despite being one of the few states in the USA requiring adolescent girls receive the vaccine. Provider characteristics may be an important factor in HPV vaccination. Thus, the present study assessed provider vaccination, practices, knowledge about the vaccine, and confidence in performing behaviors related to the vaccine. We conducted a cross-sectional electronic survey in a large health care system in Northern Virginia. A total of 53 responses were received. Only respondents who reported seeing adolescent patients were included in analyses (N = 42). Differences in responses were examined by provider age, gender, and type. Respondents reported recommending the vaccine a high percent of the time to eligible patients and had overall high levels of knowledge and confidence. Male providers recommended the vaccine to boys ages 11–12, less frequently than female providers. Providers age 50 and over recommended the vaccine to boys ages 11–12 less frequently than younger providers. This study shows that there are some gaps in HPV vaccine recommendation practices among providers. These gaps may be one reason for the low uptake of the HPV vaccine among adolescents. Thus, educational and training interventions of providers could be considered.
KeywordsCancer HPV vaccine Cervical cancer Health care providers
Merck & Co., Inc. was involved in the design of questionnaire and approved the present manuscript.
Merck & Co., Inc., Kenilworth, NJ, USA provided financial support for the study.
- 3.Markowitz LE, Hariri S, Lin C, Dunne EF, Steinau M, McQuillan G, Unger ER (2013) Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and nutrition examination surveys, 2003–2010. J Infect Dis 208(3):385–393. https://doi.org/10.1093/infdis/jit192 CrossRefPubMedGoogle Scholar
- 4.Reagan-Steiner S, Yankey D, Jeyarajah J, et al. (2016) National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years—United States, 2015. MMWR. Morbidity and mortality weekly report; 65Google Scholar
- 9.Centers for Disease Control and Prevention (2016) Adolescent human papillomavirus (HPV) vaccination coverage report. Centers for Disease Control and Prevention, . 2017. https://www.cdc.gov/vaccines/imz-managers/coverage/teenvaxview/data-reports/hpv/reports/2016.html. Accessed October 2 2017
- 10.National Conference of State Legislators (2017) HPV Vaccine: State Legislation and Statutes. National Conference of State Legislators,, Denver. http://www.ncsl.org/research/health/hpv-vaccine-state-legislation-and-statutes.aspx. Accessed October 2 2017
- 13.Opel DJ, Robinson JD, Heritage J, Korfiatis C, Taylor JA, Mangione-Smith R (2012) Characterizing providers’ immunization communication practices during health supervision visits with vaccine-hesitant parents: a pilot study. Vaccine 30(7):1269–1275. https://doi.org/10.1016/j.vaccine.2011.12.129 CrossRefPubMedGoogle Scholar
- 15.Verger P, Fressard L, Collange F, Gautier A, Jestin C, Launay O, Raude J, Pulcini C, Peretti-Watel P (2015) Vaccine hesitancy among general practitioners and its determinants during controversies: a National Cross-sectional Survey in France. EBioMed 2(8):891–897. https://doi.org/10.1016/j.ebiom.2015.06.018 CrossRefGoogle Scholar
- 19.Centers for Disease Control and Prevention (2016) CDC recommends only two HPV shots for younger adolescents. https://www.cdc.gov/media/releases/2016/p1020-hpv-shots.html. Accessed September 14 2017